Beleaguered Merck looks to future
Beleaguered Merck looks to future “A week after saying it was withdrawing its $2.5 billion arthritis drug Vioxx from the […]
Beleaguered Merck looks to future “A week after saying it was withdrawing its $2.5 billion arthritis drug Vioxx from the […]
FDA Eases Rules on Drug Manufacturing “Drug makers will not need regulatory approval for every change in their manufacturing processes
Online Extra: “It’s a Perfect Storm” for Drugmakers: “Glaxo CEO Jean-Pierre Garnier on the industry’s hardships and how his company
Online Extra: "It's a Perfect Storm" for Drugmakers Read Post »
Online Extra: “It’s a Perfect Storm” for Drugmakers: “Glaxo CEO Jean-Pierre Garnier on the industry’s hardships and how his company
Online Extra: “It’s a Perfect Storm” for Drugmakers Read Post »
It’s a Perfect Storm” for Drugmakers “Glaxo CEO Jean-Pierre Garnier on the industry’s hardships and how his company is improving
It’s a Perfect Storm” for Drugmakers “Glaxo CEO Jean-Pierre Garnier on the industry’s hardships and how his company is improving
Long Trip for Psychedelic Drugs “Psychedelic drugs are inching their way slowly but surely toward prescription status in the United
Genetically altered grass spreads like wildfire “A new study shows that genes from genetically engineered grass can spread much farther
How Dublin Keeps Big Pharma Happy “It’s moving from basic manufacturing to sophisticated R&D to fend off rivals”
The Trials of ImClone “A founder in handcuffs, financials in disarray, and a vital product in doubt-for CEO Daniel Lynch,
Get new actionable insights and updates from BiotechBlog